The UCCRC Senior Leadership consists of the Director, two Co-Deputy Directors, and 7 Associate Directors. The composition and structure of this team has changed over the past five years, reflecting UCCRC planning and evaluation activities, new initiatives and approaches at the level of the Biological Sciences Division (BSD), new recruitments, and new UCCRC strategic initiatives and overall goals. In April 2004, Dr. Le Beau succeeded Dr. Vogelzang as UCCRC Director. To facilitate translational research, as well as to optimize integration of both clinical and basic research, Dr. Le Beau appointed two Deputy Directors: Dr. Marsha Rosner, the Charles B. Muggins Professor, Chair of the Ben May Department for Cancer Research and an experienced basic researcher, and Dr. Everett Vokes, the John E. Ultmann Professor and Director of the Section of Hematology/Oncology, PI of the NCI Phase II contract and an experienced clinical researcher. Both Drs. Rosner and Vokes have previously held senior leadership roles within the UCCRC. Dr. Marcy List continues in her role as Associate Director for Administration, and her responsibilities have been expanded. Drs. Greene and Ratain continue in their roles as Associate Director for Basic Sciences, Education and Training, and Associate Director for Clinical Sciences, respectively. To expand our efforts in cancer epidemiology, prevention, and control, we recruited Habibul Ahsan, MD, who assumed the position of UCCRC Associate Director for Population Research in December 2006. To facilitate the enhancement of community outreach programs and recruitment of minorities to clinical trials, as well as to expand our research portfolio in health disparities, Rick Kittles, PhD, was recruited in August 2006 and has assumed the newly-created position of UCCRC Associate Director for Diversity and Community Outreach. Recognizing the need to upgrade informatics activities in support of UCCRC researchers and to train faculty and staff in the use of existing technologies, Yves Lussier, MD, recruited in Jan 2006, was appointed UCCRC Associate Director for Biomedical Informatics. Finally, to oversee and integrate UCCRC core facilities with those of the BSD, Julie Auger, BS, Director of the BSD Office of Shared Research Facilities was appointed UCCRC Associate Director for Core Facilities. The above individuals are members of the Cancer Advisory Committee (CAC), which also includes additional leaders of academic units engaged in cancer research and care of patients with cancer, e.g., Radiation Oncology, Surgical Oncology, and Pediatric Oncology. The CAC oversees all UCCRC activities, including strategic planning, programmatic development, development of shared resources, recruitment, and oversight of the pilot project program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-37
Application #
8375689
Study Section
Special Emphasis Panel (ZCA1-RTRB-N)
Project Start
Project End
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
37
Fiscal Year
2012
Total Cost
$295,875
Indirect Cost
$103,429
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Liu, Hongtao; Zha, Yuanyuan; Choudhury, Noura et al. (2018) WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia. Exp Hematol Oncol 7:1
Nageeb, Shaheen; Vu, Milkie; Malik, Sana et al. (2018) Adapting a religious health fatalism measure for use in Muslim populations. PLoS One 13:e0206898
Ferreira, Caroline M; Williams, Jesse W; Tong, Jiankun et al. (2018) Allergen Exposure in Lymphopenic Fas-Deficient Mice Results in Persistent Eosinophilia Due to Defects in Resolution of Inflammation. Front Immunol 9:2395
Luke, Jason J; Lemons, Jeffrey M; Karrison, Theodore G et al. (2018) Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. J Clin Oncol 36:1611-1618
Wang, Amy Y; Weiner, Howard; Green, Margaret et al. (2018) A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. J Hematol Oncol 11:4
Sample, Ashley; He, Yu-Ying (2018) Mechanisms and prevention of UV-induced melanoma. Photodermatol Photoimmunol Photomed 34:13-24
Jeong, Choongwon; Witonsky, David B; Basnyat, Buddha et al. (2018) Detecting past and ongoing natural selection among ethnically Tibetan women at high altitude in Nepal. PLoS Genet 14:e1007650
Wang, Xin; Wu, Xingye; Zhang, Zhonglin et al. (2018) Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway. Sci Rep 8:17914
Brown, Hailey M; Biering, Scott B; Zhu, Allen et al. (2018) Demarcation of Viral Shelters Results in Destruction by Membranolytic GTPases: Antiviral Function of Autophagy Proteins and Interferon-Inducible GTPases. Bioessays 40:e1700231
Karrison, Theodore; Kocherginsky, Masha (2018) Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials? Clin Trials 15:178-188

Showing the most recent 10 out of 668 publications